Literature DB >> 16705174

Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling.

Zhiping Li1, Chenguang Wang, Xuanmao Jiao, Yinan Lu, Maofu Fu, Andrew A Quong, Chip Dye, Jianguo Yang, Maozheng Dai, Xiaoming Ju, Xueping Zhang, Anping Li, Peter Burbelo, E Richard Stanley, Richard G Pestell.   

Abstract

Cyclin D1 is overexpressed in human tumors, correlating with cellular metastasis, and is induced by activating Rho GTPases. Herein, cyclin D1-deficient mouse embryo fibroblasts (MEFs) exhibited increased adhesion and decreased motility compared with wild-type MEFs. Retroviral transduction of cyclin D1 reversed these phenotypes. Mutational analysis of cyclin D1 demonstrated that its effects on cellular adhesion and migration were independent of the pRb and p160 coactivator binding domains. Genomewide expression arrays identified a subset of genes regulated by cyclin D1, including Rho-activated kinase II (ROCKII) and thrombospondin 1 (TSP-1). cyclin D1(-/-) cells showed increased Rho GTP and ROCKII activity and signaling, with increased phosphorylation of LIM kinase, cofilin (Ser3), and myosin light chain 2 (Thr18/Ser19). Cyclin D1 repressed ROCKII and TSP-1 expression, and the migratory defect of cyclin D1(-/-) cells was reversed by ROCK inhibition or TSP-1 immunoneutralizing antibodies. cyclin E knockin to the cyclin D1(-/-) MEFs rescued the DNA synthesis defect of cyclin D1(-/-) MEFs but did not rescue either the migration defect or the abundance of ROCKII. Cyclin D1 promotes cellular motility through inhibiting ROCK signaling and repressing the metastasis suppressor TSP-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705174      PMCID: PMC1489104          DOI: 10.1128/MCB.02124-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  82 in total

1.  Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases.

Authors:  E A Cox; S K Sastry; A Huttenlocher
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

Review 2.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Altered Rho GTPase signaling pathways in breast cancer cells.

Authors:  Peter Burbelo; Anton Wellstein; Richard G Pestell
Journal:  Breast Cancer Res Treat       Date:  2004-03       Impact factor: 4.872

4.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

5.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.

Authors:  M Streit; P Velasco; L F Brown; M Skobe; L Richard; L Riccardi; J Lawler; M Detmar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.

Authors:  Toula Bouras; Maofu Fu; Anthony A Sauve; Fang Wang; Andrew A Quong; Neil D Perkins; Ronald T Hay; Wei Gu; Richard G Pestell
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

8.  Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Authors:  Chenguang Wang; Nagarajan Pattabiraman; Jian Nian Zhou; Maofu Fu; Toshiyuki Sakamaki; Chris Albanese; Zhiping Li; Kongming Wu; James Hulit; Peter Neumeister; Phyllis M Novikoff; Michael Brownlee; Philipp E Scherer; Joan G Jones; Kathleen D Whitney; Lawrence A Donehower; Emily L Harris; Thomas Rohan; David C Johns; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun.

Authors:  J K Westwick; R J Lee; Q T Lambert; M Symons; R G Pestell; C J Der; I P Whitehead
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

10.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover.

Authors:  X D Ren; W B Kiosses; D J Sieg; C A Otey; D D Schlaepfer; M A Schwartz
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  85 in total

1.  ErbB2 induces Notch1 activity and function in breast cancer cells.

Authors:  Jaime Lindsay; Xuanmao Jiao; Toshiyuki Sakamaki; Mathew C Casimiro; Lawrence A Shirley; Thai H Tran; Xiaoming Ju; Manran Liu; Zhiping Li; Chenguang Wang; Sanjay Katiyar; Mahadev Rao; Kathleen G Allen; Robert I Glazer; Changhui Ge; Pamela Stanley; Michael P Lisanti; Hallgeir Rui; Richard G Pestell
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

2.  ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Adam Ertel; Zuoren Yu; William Dampier; Elizabeth A Saria; Alex Papanikolaou; Timothy J Stanek; Zhiping Li; Chenguang Wang; Paolo Fortina; Sankar Addya; Aydin Tozeren; Erik S Knudsen; Andrew Arnold; Richard G Pestell
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

3.  Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.

Authors:  Zhijiu Zhong; Wen-Shuz Yeow; Chunhua Zou; Richard Wassell; Chenguang Wang; Richard G Pestell; Judy N Quong; Andrew A Quong
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

4.  Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features.

Authors:  Sophie Lehn; Nicholas P Tobin; Pontus Berglund; Kristina Nilsson; Andrew H Sims; Karin Jirström; Pirkko Härkönen; Rebecca Lamb; Göran Landberg
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration.

Authors:  Catherine McCusker; Hélène Cousin; Russell Neuner; Dominique Alfandari
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

Review 6.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

7.  The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.

Authors:  Ke Chen; Kongming Wu; Xuanmao Jiao; Liping Wang; Xiaoming Ju; Min Wang; Gabriele Di Sante; Shaohua Xu; Qiong Wang; Kevin Li; Xin Sun; Congwen Xu; Zhiping Li; Mathew C Casimiro; Adam Ertel; Sankar Addya; Peter A McCue; Michael P Lisanti; Chenguang Wang; Richard J Davis; Graeme Mardon; Richard G Pestell
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

Review 8.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

9.  Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.

Authors:  Venkatesh Kundumani-Sridharan; Dong Wang; Manjula Karpurapu; Zhimin Liu; Chunxiang Zhang; Nagadhara Dronadula; Gadiparthi N Rao
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.

Authors:  Xuanmao Jiao; Sanjay Katiyar; Nicole E Willmarth; Manran Liu; Xiaojing Ma; Neal Flomenberg; Michael P Lisanti; Richard G Pestell
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.